Taisho Pharmaceutical Co. is in talks with Astellas Pharma Inc. to buy its over-the-counter drug unit Zepharma Inc., sources said Thursday.

The two firms will soon make a final decision, the sources said. If the deal is struck, Astellas will withdraw from the OTC drug market and concentrate on prescription drugs.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.